Prediction value of neutrophil and eosinophil count at risk of COPD exacerbation

References

• Soler-Cataluna JJ, Martinez GM, Roman SP, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):1–7. doi: 10.1136/thx.2005.040527.
   PubMed Web of Science ®Google Scholar
• Yoon HY, Park SY, Lee CH, et al. Prediction of first acute exacerbation using COPD subtypes identified by cluster analysis. Int J Chron Obstruct Pulmon Dis. 2019;14:1389–1397. doi: 10.2147/COPD.S205517.
   PubMed Web of Science ®Google Scholar
• Huebner ST, Henny S, Giezendanner S, et al. Prediction of acute COPD exacerbation in the swiss multicenter COPD cohort study (TOPDOCS) by clinical parameters, medication use, and immunological biomarkers. Respiration. 2022;101(5):441–454. doi: 10.1159/000520196.
   PubMed Web of Science ®Google Scholar
• Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138. doi: 10.1056/NEJMoa0909883.
   PubMed Web of Science ®Google Scholar
• Safari A, Adibi A, Sin DD, et al. ACCEPT 2.0: recalibrating and externally validating the acute COPD exacerbation prediction tool (ACCEPT). EClinicalMedicine. 2022;51:101574. doi: 10.1016/j.eclinm.2022.101574.
   PubMedGoogle Scholar
• Ergan B, Şahin AA, Topeli A. Serum procalcitonin as a biomarker for the prediction of bacterial exacerbation and mortality in severe COPD exacerbations requiring mechanical ventilation. Respiration. 2016;91(4):316–324. doi: 10.1159/000445440.
   PubMed Web of Science ®Google Scholar
• Hoult G, Gillespie D, Wilkinson TMA, et al. Biomarkers to guide the use of antibiotics for acute exacerbations of COPD (AECOPD): a systematic review and meta-analysis. BMC Pulm Med. 2022;22(1):194. doi: 10.1186/s12890-022-01958-4.
   PubMed Web of Science ®Google Scholar
• Tong X, Wang D, Liu S, et al. The YKL-40 protein is a potential biomarker for COPD: a meta-analysis and systematic review. Int J Chron Obstruct Pulmon Dis. 2018;13:409–418. doi: 10.2147/COPD.S15265529430175.
   PubMed Web of Science ®Google Scholar
• Guerra B, Gaveikaite V, Bianchi C, et al. Prediction models for exacerbations in patients with COPD. Eur Respir Rev. 2017;26(143):160061. doi: 10.1183/16000617.0061-2016.
   PubMed Web of Science ®Google Scholar
• Bafadhel M, McKenna S, Terry S, et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med. 2011;184(6):662–671. doi: 10.1164/rccm.201104-0597OC.
   PubMed Web of Science ®Google Scholar
• Gil HI, Zo S, Jones PW, et al. Clinical characteristics of COPD patients according to COPD assessment test (CAT) score level: cross-sectional study. Int J Chron Obstruct Pulmon Dis. 2021;16:1509–1517. doi: 10.2147/COPD.S297089.
   PubMed Web of Science ®Google Scholar
• Launois C, Barbe C, Bertin E, et al. The modified Medical Research Council scale for the assessment of dyspnea in daily living in obesity: a pilot study. BMC Pulm Med. 2012;12(1):61. doi: 10.1186/1471-2466-12-61.
   PubMedGoogle Scholar
• ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS committee on proficiency standards for clinical pulmonary function laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111–117.
   PubMed Web of Science ®Google Scholar
• Tsai DH, Riediker M, Wuerzner G, et al. Short-term increase in particulate matter blunts nocturnal blood pressure dipping and daytime urinary sodium excretion. Hypertension. 2012;60(4):1061–1069. doi: 10.1161/HYPERTENSIONAHA.112.195370.
   PubMed Web of Science ®Google Scholar
• Lonergan M, Dicker AJ, Crichton ML, et al. Blood neutrophil counts are associated with exacerbation frequency and mortality in COPD. Respir Res. 2020;21(1):166. doi: 10.1186/s12931-020-01436-7.
   PubMed Web of Science ®Google Scholar
• Chen TT, Wu SM, Chen KY, et al. Suppressor of variegation 3–9 homologue 1 impairment and neutrophil-skewed systemic inflammation are associated with comorbidities in COPD. BMC Pulm Med. 2021;21(1):276. doi: 10.1186/s12890-021-01628-x.
   PubMed Web of Science ®Google Scholar
• Wu X, Wang C, Li H, et al. Circulating white blood cells and lung function impairment: the observational studies and Mendelian randomization analysis. Ann Med. 2021;53(1):1118–1128. doi: 10.1080/07853890.2021.1948603.
   PubMed Web of Science ®Google Scholar
• Smith CJ, Kluck LA, Ruan GJ, et al. Leukocytosis and tobacco use: an observational study of asymptomatic leukocytosis. Am J Med. 2021;134(1):e31–e35. doi: 10.1016/j.amjmed.2020.06.014.
   PubMed Web of Science ®Google Scholar
• Shui LL, Cai JJ, Zhong XQ, et al. Chronic obstructive pulmonary disease patients with high peripheral blood eosinophil counts have better predicted improvement in 6MWD after rehabilitation: a PRELIMINARY STUDY. J Cardiopulm Rehabil Prev. 2023;43(2):122–128.
   PubMed Web of Science ®Google Scholar
• Hastie AT, Martinez FJ, Curtis JL, et al. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort. Lancet Respir Med. 2017;5(12):956–967. doi: 10.1016/S2213-2600(17)30432-0.
   PubMed Web of Science ®Google Scholar
• Semenzato U, Biondini D, Bazzan E, et al. Low-blood lymphocyte number and lymphocyte decline as key factors in COPD outcomes: a longitudinal cohort study. Respiration. 2021;100(7):618–630. doi: 10.1159/000515180.
   PubMed Web of Science ®Google Scholar
• Guo R, Li J, Ma X, et al. The predictive value of neutrophil-to-lymphocyte ratio for chronic obstructive pulmonary disease: a systematic review and meta-analysis. Expert Rev Respir Med. 2020;14(9):929–936. doi: 10.1080/17476348.2020.1776613.
   PubMed Web of Science ®Google Scholar
• Gao J, Chen B, Wu S, et al. Blood cell for the differentiation of airway inflammatory phenotypes in COPD exacerbations. BMC Pulm Med. 2020;20(1):50. doi: 10.1186/s12890-020-1086-1.
   PubMed Web of Science ®Google Scholar
• Kang HS, Kim SK, Kim YH, et al. The association between eosinophilic exacerbation and eosinophilic levels in stable COPD. BMC Pulm Med. 2021;21(1):74. doi: 10.1186/s12890-021-01443-4.
   PubMed Web of Science ®Google Scholar
• Aksoy E, Karakurt Z, Gungor S, et al. Neutrophil to lymphocyte ratio is a better indicator of COPD exacerbation severity in neutrophilic endotypes than eosinophilic endotypes. Int J Chron Obstruct Pulmon Dis. 2018;13:2721–2730. doi: 10.2147/COPD.S170353.
   PubMed Web of Science ®Google Scholar
• Cekici Y, Yilmaz M, Secen O. New inflammatory indicators: association of high eosinophil-to-lymphocyte ratio and low lymphocyte-to-monocyte ratio with smoking. J Int Med Res. 2019;47(9):4292–4303. doi: 10.1177/0300060519862077.
   PubMed Web of Science ®Google Scholar